サマリー

血管パッチの世界市場は、2022年に推定3億5300万米ドルと評価され、予測期間中にCAGR7.9％で2027年までに5億1700万米ドルに達すると予測されています。市場の成長は、CVDの発生率の上昇、外科手術の量の増加、血管手術のための生物学的パッチの採用の増加といった要因によってもたらされます。
"素材別では、生物学的血管パッチが血管パッチ市場で最大のシェアを占めた"
素材別に、世界の血管パッチ市場は、生物学的血管パッチと合成血管パッチに区分される。生物学的血管パッチは、市場で大きなシェアを占めています。また、同市場で最も成長率の高い素材セグメントである。このセグメントの成長は主に、合成パッチと比較して生物学的パッチが提供する利点によって駆動されます。
"血管バイパス手術セグメントが血管パッチ市場の用途別最速成長セグメント"
血管パッチ市場は用途別に、頸動脈内膜切除術（CEA）、腹部大動脈瘤（AAA）の開放修復、先天性心疾患、血管バイパス手術、その他の用途に区分される。血管バイパス手術は、予測期間中に最も速い成長を目撃すると予想されます。血管バイパス手術の高い成長率は、新興国および先進国での償還が可能であることに起因しています。
「エンドユーザーのうち、病院分野は予測期間中に最も高い成長を記録すると予想される。
エンドユーザーに基づいて、血管パッチ市場は病院と外来手術センターに区分されます。病院分野は、予測期間中に最も高い成長率を記録すると予想されます。この成長は、より良い医療サービスやインフラを提供する病院が増加していることに起因している可能性があります。
「アジア太平洋地域は、予測期間中に最も高いCAGRで成長すると予想される。
血管パッチの世界市場は、北米、欧州、アジア太平洋地域、その他の地域の4地域に区分されます。アジア太平洋地域は、予測期間中に血管パッチ市場で最も高い成長を目撃すると予想されます。この地域の高成長は、主に対象人口が多いことと、東南アジア諸国の医療インフラが整備されていることに起因しています。
本レポートのために実施した主なインタビューは、以下のように分類することができます。

- 企業タイプ別企業タイプ別：Tier1 30％、Tier2 45％、Tier3 25
- 役職別Cレベル：28％、Dレベル：32％、その他：40
- 地域別地域別：北米35％、欧州21％、アジア太平洋28％、その他の地域16
レポート掲載企業リスト

- バクスター・インターナショナル社（米国）
- ルメートル・バスキュラー社（米国）
- W. L. Gore & Associates, Inc.（米国）
- ゲティンゲ社（スウェーデン）
- ビーブラウン（ドイツ）
- アーティビオン社（米国）
- エドワーズライフサイエンス社（米国）
- アジヨバイオロジクス株式会社（米国）
- テルモ株式会社（日本）
- BD（米国）
- Labcor Laboratórios Ltda. (ブラジル)
- VUP Medical（チェコ）
- イージスライフサイエンス（インド）
- シンクロマックス・バイオテック社（インド） SynkroMax Biotech Pvt.(インド)

調査対象範囲
本レポートは、世界の血管パッチの市場に関する詳細な情報を提供します。材料、用途、エンドユーザー、地域などの異なるセグメントにおける市場規模や今後の成長性を推定することを目的としています。また、主要な市場プレイヤーの企業プロファイル、最近の開発、主要な市場戦略とともに、詳細な競合分析も行っています。

レポート購入の主なメリット
本レポートは、血管パッチ市場全体とそのサブセグメントに関する収益数の最も近い概算を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をより良く理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を立てるためのより多くの洞察を得るのに役立ちます。本レポートは、利害関係者が市場の脈動を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。

ページTOPに戻る

目次

1 INTRODUCTION 19
1.1 STUDY OBJECTIVES 19
1.2 MARKET DEFINITION 19
1.2.1 INCLUSIONS & EXCLUSIONS 20
1.3 MARKET SCOPE 20
FIGURE 1 VASCULAR PATCHES MARKET 20
1.3.1 YEARS CONSIDERED 21
1.4 CURRENCY CONSIDERED 21
1.5 STAKEHOLDERS 21
1.6 SUMMARY OF CHANGES 21
1.7 LIMITATIONS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
FIGURE 2 RESEARCH DESIGN 23
2.1.1 SECONDARY SOURCES 23
2.1.1.1 Secondary sources 25
2.1.2 PRIMARY DATA 25
2.1.2.1 Key data from primary sources 26
2.1.2.2 Key industry insights 27
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 27
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 28
2.2 MARKET SIZE ESTIMATION 28
2.2.1 BOTTOM-UP APPROACH 29
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 29
FIGURE 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 30
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 30
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 31
FIGURE 8 DATA TRIANGULATION METHODOLOGY 31
2.4 MARKET SHARE ANALYSIS 32
2.5 STUDY ASSUMPTIONS 32
2.6 RISK ASSESSMENT 32
TABLE 1 RISK ASSESSMENT: VASCULAR PATCHES MARKET 32
2.7 LIMITATIONS 33
2.7.1 METHODOLOGY-RELATED LIMITATIONS 33
2.7.2 SCOPE-RELATED LIMITATIONS 33
2.8 GROWTH RATE ASSUMPTIONS 33
3 EXECUTIVE SUMMARY 34
FIGURE 9 VASCULAR PATCHES MARKET, BY MATERIAL, 2022 VS. 2027 (USD MILLION) 34
FIGURE 10 VASCULAR PATCHES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 35
FIGURE 11 VASCULAR PATCHES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 35
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF VASCULAR PATCHES MARKET 36
4 PREMIUM INSIGHTS 37
4.1 VASCULAR PATCHES MARKET OVERVIEW 37
FIGURE 13 RISING PREVALENCE OF CVD AND GROWING VOLUME OF CARDIOVASCULAR SURGERIES TO DRIVE MARKET 37
4.2 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL (2021) 38
FIGURE 14 BIOLOGICAL VASCULAR PATCHES ACCOUNTED FOR LARGEST SHARE IN 2021 38
4.3 VASCULAR PATCHES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 39
FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 39
4.4 VASCULAR PATCHES MARKET: GEOGRAPHIC MIX 39
FIGURE 16 ASIA PACIFIC MARKET TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 39
4.5 VASCULAR PATCHES MARKET: DEVELOPED VS. EMERGING ECONOMIES 40
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
FIGURE 18 VASCULAR PATCHES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
5.2.1 DRIVERS 42
5.2.1.1 Rising incidence of CVD 42
5.2.1.2 Growing geriatric population and subsequent prevalence of vascular diseases 42
5.2.1.3 Rising number of cardiovascular surgeries worldwide 43
5.2.1.4 Availability of reimbursement for vascular procedures 43
5.2.1.5 Growing adoption of biological patches 44
5.2.2 RESTRAINTS 44
5.2.2.1 High procedural cost of vascular surgeries and associated products 44
5.2.2.2 Product failures and recalls 44
5.2.3 OPPORTUNITIES 45
5.2.3.1 Emerging economies 45
5.2.3.2 Growth in the number of hospitals & surgical centers 45
5.2.4 CHALLENGES 46
5.2.4.1 Lack of skilled professionals 46
5.3 REGULATORY LANDSCAPE 46
TABLE 2 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 46
TABLE 3 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 47
TABLE 4 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 47
TABLE 5 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 47
5.3.1 NORTH AMERICA 48
5.3.1.1 US 48
5.3.1.2 Canada 48
5.3.2 EUROPE 48
5.3.3 ASIA PACIFIC 48
5.3.3.1 China 48
5.3.3.2 Japan 48
5.3.3.3 India 48
5.3.4 LATIN AMERICA 49
5.3.4.1 Brazil 49
5.3.4.2 Mexico 49
5.3.5 MIDDLE EAST 49
5.3.6 AFRICA 50
5.4 PORTER’S FIVE FORCES ANALYSIS 50
TABLE 6 VASCULAR PATCHES MARKET: PORTER’S FIVE FORCES ANALYSIS 50
5.4.1 THREAT FROM NEW ENTRANTS 50
5.4.2 THREAT FROM SUBSTITUTES 50
5.4.3 BARGAINING POWER OF BUYERS 50
5.4.4 BARGAINING POWER OF SUPPLIERS 51
5.4.5 DEGREE OF COMPETITION 51
5.5 TECHNOLOGY ANALYSIS 51
5.6 VALUE CHAIN ANALYSIS 51
5.7 SUPPLY CHAIN ANALYSIS 52
FIGURE 19 VASCULAR PATCHES MARKET: SUPPLY CHAIN ANALYSIS 53
5.8 ECOSYSTEM ANALYSIS 53
FIGURE 20 VASCULAR PATCHES MARKET: ECOSYSTEM ANALYSIS 54
5.8.1 ECOSYSTEM ROLE 54
6 VASCULAR PATCHES MARKET, BY MATERIAL 55
6.1 INTRODUCTION 56
TABLE 7 VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 56
6.2 BIOLOGIC VASCULAR PATCHES 56
6.2.1 WIDE USAGE IN ARTERIAL CLOSURE DURING CARDIAC SURGERIES TO DRIVE MARKET 56
TABLE 8 BIOLOGIC VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION) 57
6.3 SYNTHETIC VASCULAR PATCHES 57
6.3.1 HIGH RISK OF INFECTION DESPITE BEING COST-EFFICIENT TO RESTRAIN MARKET 57
TABLE 9 SYNTHETIC VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION) 57
7 VASCULAR PATCHES MARKET, BY APPLICATION 58
7.1 INTRODUCTION 59
TABLE 10 VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59
7.2 CAROTID ENDARTERECTOMY 59
7.2.1 INCREASING PATCH ANGIOPLASTY PROCEDURES TO DRIVE MARKET 59
TABLE 11 VASCULAR PATCHES MARKET FOR CAROTID ENDARTERECTOMY, BY REGION, 2020–2027 (USD MILLION) 60
7.3 VASCULAR BYPASS SURGERY 60
7.3.1 RISING PREVALENCE OF VASCULAR DISEASES TO DRIVE MARKET 60
TABLE 12 VASCULAR PATCHES MARKET FOR VASCULAR BYPASS SURGERY, BY REGION, 2020–2027 (USD MILLION) 60
7.4 CONGENITAL HEART DISEASE 61
7.4.1 USE OF SYNTHETIC & BIOLOGIC VASCULAR PATCHES FOR CORRECTIVE SURGERIES TO DRIVE MARKET 61
TABLE 13 VASCULAR PATCHES MARKET FOR CONGENITAL HEART DISEASE, BY REGION, 2020–2027 (USD MILLION) 61
7.5 OPEN REPAIR OF ABDOMINAL AORTIC ANEURYSM 61
7.5.1 RISING INCIDENCE OF AAA TO DRIVE DEMAND FOR VASCULAR PATCHES 61
TABLE 14 VASCULAR PATCHES MARKET FOR OPEN REPAIR OF ABDOMINAL AORTIC ANEURYSM, BY REGION, 2020–2027 (USD MILLION) 62
7.6 OTHER APPLICATIONS 62
TABLE 15 VASCULAR PATCHES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 63
8 VASCULAR PATCHES MARKET, BY END USER 64
8.1 INTRODUCTION 65
TABLE 16 VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 65
8.2 HOSPITALS 65
8.2.1 RISING BURDEN OF CVD AND DEVELOPING INFRASTRUCTURE IN EMERGING ECONOMIES TO DRIVE MARKET 65
TABLE 17 VASCULAR PATCHES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 66
8.3 AMBULATORY SURGICAL CENTERS 66
8.3.1 RISING NUMBER OF ASCS TO PROPEL MARKET GROWTH 66
TABLE 18 VASCULAR PATCHES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2027 (USD MILLION) 66
9 VASCULAR PATCHES MARKET, BY REGION 67
9.1 INTRODUCTION 68
TABLE 19 VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION) 68
9.2 NORTH AMERICA 68
FIGURE 21 NORTH AMERICA: VASCULAR PATCHES MARKET SNAPSHOT 69
TABLE 20 NORTH AMERICA: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 69
TABLE 21 NORTH AMERICA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 70
TABLE 22 NORTH AMERICA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70
TABLE 23 NORTH AMERICA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 70
9.2.1 US 71
9.2.1.1 Favorable government reimbursements for vascular surgeries to drive market 71
TABLE 24 US: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 71
TABLE 25 US: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 71
TABLE 26 US: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 72
9.2.2 CANADA 72
9.2.2.1 High incidence of vascular diseases to support market growth 72
TABLE 27 CANADA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 72
TABLE 28 CANADA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 73
TABLE 29 CANADA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 73
9.3 EUROPE 73
TABLE 30 EUROPE: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74
TABLE 31 EUROPE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 74
TABLE 32 EUROPE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74
TABLE 33 EUROPE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 75
9.3.1 GERMANY 75
9.3.1.1 Presence of a large target patient population to support market growth 75
TABLE 34 GERMANY: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 75
TABLE 35 GERMANY: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 76
TABLE 36 GERMANY: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 76
9.3.2 FRANCE 76
9.3.2.1 High prevalence of CVD to drive demand for vascular patches 76
TABLE 37 FRANCE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 77
TABLE 38 FRANCE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 77
TABLE 39 FRANCE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 77
9.3.3 UK 78
9.3.3.1 Rising geriatric population and subsequent prevalence of CHD to drive market 78
TABLE 40 UK: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 78
TABLE 41 UK: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 79
TABLE 42 UK: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 79
9.3.4 ITALY 79
9.3.4.1 Increasing incidence of CHD to support market growth 79
TABLE 43 ITALY: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 80
TABLE 44 ITALY: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 80
TABLE 45 ITALY: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 80
9.3.5 SPAIN 81
9.3.5.1 Rising risk of developing CVD due to age-related disorders to support market growth 81
TABLE 46 SPAIN: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 81
TABLE 47 SPAIN: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 81
TABLE 48 SPAIN: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 82
9.3.6 REST OF EUROPE 82
TABLE 49 REST OF EUROPE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 82
TABLE 50 REST OF EUROPE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83
TABLE 51 REST OF EUROPE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 83
9.4 ASIA PACIFIC 83
FIGURE 22 ASIA PACIFIC: VASCULAR PATCHES MARKET SNAPSHOT (2021) 84
TABLE 52 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
TABLE 53 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 85
TABLE 54 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 85
TABLE 55 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 86
9.4.1 CHINA 86
9.4.1.1 Rising prevalence of chronic heart diseases to drive market 86
TABLE 56 CHINA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 86
TABLE 57 CHINA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87
TABLE 58 CHINA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 87
9.4.2 JAPAN 87
9.4.2.1 Rising public healthcare spending to drive demand for vascular patches 87
TABLE 59 JAPAN: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 88
TABLE 60 JAPAN: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 88
TABLE 61 JAPAN: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 88
9.4.3 INDIA 89
9.4.3.1 Rising incidence of CVD to drive market 89
TABLE 62 INDIA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 89
TABLE 63 INDIA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 89
TABLE 64 INDIA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 90
9.4.4 REST OF ASIA PACIFIC 90
TABLE 65 REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 91
TABLE 66 REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 91
TABLE 67 REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 91
9.5 REST OF THE WORLD 92
TABLE 68 REST OF THE WORLD: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 92
TABLE 69 REST OF THE WORLD: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93
TABLE 70 REST OF THE WORLD: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 93
10 COMPETITIVE LANDSCAPE 94
10.1 OVERVIEW 94
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 94
TABLE 71 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS 94
10.3 REVENUE SHARE ANALYSIS 95
FIGURE 23 VASCULAR PATCHES MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS 96
10.4 MARKET SHARE ANALYSIS 96
TABLE 72 VASCULAR PATCHES MARKET: DEGREE OF COMPETITION 96
FIGURE 24 VASCULAR PATCHES MARKET SHARE ANALYSIS, 2021 97
10.5 COMPANY EVALUATION QUADRANT 98
10.5.1 STARS 98
10.5.2 EMERGING LEADERS 98
10.5.3 PERVASIVE PLAYERS 98
10.5.4 PARTICIPANTS 98
FIGURE 25 VASCULAR PATCHES MARKET: COMPANY EVALUATION QUADRANT (2021) 99
10.6 COMPANY FOOTPRINT ANALYSIS 99
TABLE 73 COMPANY FOOTPRINT 99
TABLE 74 COMPANY MATERIAL FOOTPRINT 100
TABLE 75 COMPANY REGIONAL FOOTPRINT 101
10.7 COMPETITIVE SCENARIO 102
10.7.1 DEALS 102
TABLE 76 VASCULAR PATCHES MARKET: DEALS, 2019–2022 102
10.7.2 OTHER DEVELOPMENTS 102
TABLE 77 VASCULAR PATCHES MARKET: OTHER DEVELOPMENTS, 2019–2022 102
11 COMPANY PROFILES 103
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 KEY PLAYERS 103
11.1.1 BAXTER INTERNATIONAL, INC. 103
TABLE 78 BAXTER INTERNATIONAL, INC: COMPANY OVERVIEW 103
FIGURE 26 BAXTER INTERNATIONAL, INC: COMPANY SNAPSHOT (2021) 104
11.1.2 LEMAITRE VASCULAR, INC. 106
TABLE 79 LEMAITRE VASCULAR, INC: COMPANY OVERVIEW 106
FIGURE 27 LEMAITRE VASCULAR, INC: COMPANY SNAPSHOT (2021) 106
11.1.3 W. L. GORE & ASSOCIATES, INC. 108
TABLE 80 W. L. GORE & ASSOCIATES: COMPANY OVERVIEW 108
11.1.4 GETINGE AB 110
TABLE 81 GETINGE AB: COMPANY OVERVIEW 110
FIGURE 28 GETINGE AB: COMPANY SNAPSHOT (2021) 110
TABLE 82 EXCHANGE RATES UTILIZED FOR CONVERSION OF SEK TO USD 111
11.1.5 B. BRAUN 112
TABLE 83 B. BRAUN: COMPANY OVERVIEW 112
FIGURE 29 B. BRAUN: COMPANY SNAPSHOT (2021) 113
TABLE 84 EXCHANGE RATES UTILIZED FOR CONVERSION OF EUROS TO USD 113
11.1.6 EDWARDS LIFESCIENCES CORPORATION 115
TABLE 85 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW 115
FIGURE 30 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2021) 116
11.1.7 BECTON, DICKINSON AND COMPANY 117
TABLE 86 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 117
FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 118
11.1.8 AZIYO BIOLOGICS, INC. 119
TABLE 87 AZIYO BIOLOGICS, INC: COMPANY OVERVIEW 119
FIGURE 32 AZIYO BIOLOGICS, INC: COMPANY SNAPSHOT (2021) 119
11.1.9 TERUMO CORPORATION 121
TABLE 88 TERUMO CORPORATION: COMPANY OVERVIEW 121
FIGURE 33 TERUMO CORPORATION: COMPANY SNAPSHOT (2022) 122
TABLE 89 EXCHANGE RATES UTILIZED FOR CONVERSION OF YEN TO USD 122
11.1.10 ARTIVION, INC. 124
TABLE 90 ARTIVION, INC.: COMPANY OVERVIEW 124
FIGURE 34 ARTIVION, INC: COMPANY SNAPSHOT (2021) 124
11.1.11 LABCOR LABORATÓRIOS LTDA. 126
TABLE 91 LABCOR LABORATÓRIOS LTDA.: COMPANY OVERVIEW 126
11.2 OTHER PLAYERS 127
11.2.1 VUP MEDICAL 127
TABLE 92 VUP MEDICAL: COMPANY OVERVIEW 127
11.2.2 AEGIS LIFESCIENCES 127
TABLE 93 AEGIS LIFESCIENCES: COMPANY OVERVIEW 127
11.2.3 SYNKROMAX BIOTECH PVT. LTD. 128
TABLE 94 SYNKROMAX BIOTECH PVT. LTD: COMPANY OVERVIEW 128
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX 129
12.1 INDUSTRY EXPERT INSIGHTS 129
12.2 DISCUSSION GUIDE 130
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 133
12.4 CUSTOMIZATION OPTIONS 135
12.5 RELATED REPORTS 135
12.6 AUTHOR DETAILS 136